ZA906187B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA906187B
ZA906187B ZA906187A ZA906187A ZA906187B ZA 906187 B ZA906187 B ZA 906187B ZA 906187 A ZA906187 A ZA 906187A ZA 906187 A ZA906187 A ZA 906187A ZA 906187 B ZA906187 B ZA 906187B
Authority
ZA
South Africa
Prior art keywords
gamma
interferons
linolenic acid
pharmaceutical compositions
enhancement
Prior art date
Application number
ZA906187A
Other languages
English (en)
Inventor
David Frederick Horrobin
Frederick Horrobin David
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of ZA906187B publication Critical patent/ZA906187B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA906187A 1989-08-10 1990-08-06 Pharmaceutical compositions ZA906187B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918294A GB8918294D0 (en) 1989-08-10 1989-08-10 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA906187B true ZA906187B (en) 1991-06-26

Family

ID=10661451

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906187A ZA906187B (en) 1989-08-10 1990-08-06 Pharmaceutical compositions

Country Status (15)

Country Link
US (1) US5580556A (fr)
EP (2) EP0678299A3 (fr)
AT (1) ATE123948T1 (fr)
AU (1) AU633603B2 (fr)
CA (1) CA2022608A1 (fr)
DE (1) DE69020267T2 (fr)
DK (1) DK0416743T3 (fr)
ES (1) ES2073533T3 (fr)
GB (1) GB8918294D0 (fr)
GR (1) GR3016980T3 (fr)
HK (1) HK53496A (fr)
IE (1) IE67773B1 (fr)
NO (1) NO903509L (fr)
NZ (1) NZ234786A (fr)
ZA (1) ZA906187B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
JP4172726B2 (ja) * 1996-05-22 2008-10-29 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド シス―ドコサヘキサエン酸とドセタキセルとの共有複合体を含有する製剤
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
US8552054B2 (en) 2001-03-23 2013-10-08 Luitpold Pharmaceuticals, Inc. Fatty amine drug conjugates
EP1423107B1 (fr) 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Conjugues d'agents pharmaceutiques et d'alcools gras
CA2436650A1 (fr) 2003-08-06 2005-02-06 Naturia Inc. Compositions d'acides linoleniques conjugues : synthese, purification et utilisations
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
US9333242B2 (en) 2012-01-19 2016-05-10 Hybrid Medical, Llc Topical therapeutic formulations
KR102391827B1 (ko) 2014-06-04 2022-04-27 디에스 바이오파마 리미티드 Dgla를 포함하는 약제학적 조성물 및 그의 용도
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
AU1933383A (en) * 1982-09-22 1984-03-29 Sentrachem Limited Composition of prostaglandins for prevention of cancer
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
US5225441A (en) * 1987-06-18 1993-07-06 Block Drug Company, Inc. Treatment of periodontal disease
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis

Also Published As

Publication number Publication date
EP0678299A2 (fr) 1995-10-25
EP0416743B1 (fr) 1995-06-21
AU6017890A (en) 1991-02-14
EP0678299A3 (fr) 1998-11-04
GB8918294D0 (en) 1989-09-20
DE69020267D1 (de) 1995-07-27
IE67773B1 (en) 1996-04-17
DE69020267T2 (de) 1996-01-25
ATE123948T1 (de) 1995-07-15
NO903509L (no) 1991-02-11
DK0416743T3 (da) 1995-08-14
US5580556A (en) 1996-12-03
NO903509D0 (no) 1990-08-09
NZ234786A (en) 1997-06-24
ES2073533T3 (es) 1995-08-16
EP0416743A1 (fr) 1991-03-13
CA2022608A1 (fr) 1991-02-11
HK53496A (en) 1996-04-03
IE902774A1 (en) 1991-02-27
GR3016980T3 (en) 1995-11-30
AU633603B2 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
GB8918294D0 (en) Pharmaceutical compositions
DE2967049D1 (en) Pharmaceutical and dietary composition comprising gamma-linolenic acids
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
ATE12732T1 (de) Pharmazeutische und diaetetische zusammensetzungen.
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
GR3006068T3 (fr)
DE3366506D1 (en) Pharmaceutical composition
AU563273B2 (en) Composition containing an essential fatty acid and niacin and/or a bile salt binder
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
TW223589B (fr)
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
BG52067B2 (en) Antihypoxic and brain-protection antidote composition